The metabolic sensors FXRα, PGC‐1 α, and SIRT1 cooperatively regulate hepatitis B virus transcription
@article{Curtil2014TheMS, title={The metabolic sensors FXR$\alpha$, PGC‐1 $\alpha$, and SIRT1 cooperatively regulate hepatitis B virus transcription}, author={Claire Curtil and Liviu Sorin Enache and Pauline Radreau and Anne-Ga{\"e}lle Dron and Caroline Scholt{\`e}s and A. Deloire and Didier Roche and Vincent Lotteau and Patrice Andr{\'e} and Christophe Rami{\`e}re}, journal={The FASEB Journal}, year={2014}, volume={28}, pages={1454 - 1463} }
Hepatitis B virus (HBV) genome transcription is highly dependent on liver‐enriched, metabolic nuclear receptors (NRs). Among others, NR farnesoid X receptor a (FXRa) enhances HBV core promoter activity and pregenomic RNA synthesis. Interestingly, two food‐withdrawal‐induced FXRα modulators, peroxisome proliferator‐activated receptor‐γ coactivator 1α (PGC‐1α) and deacetylase SIRT1, have been found to be associated with HBV genomes ex vivo. Whereas PGC‐1α induction was shown to increase HBV…
30 Citations
Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway
- BiologyScientific reports
- 2016
It is identified that RSV enhances HBV transcription and replication especially acting on the core promoter, which depends on Sirt1-PGC-1α-PPARα pathway, and patients with hepatitis B infection should be cautious taking RSV as a dietary supplement.
Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription.
- Biology, ChemistryBiochimica et biophysica acta. Gene regulatory mechanisms
- 2017
Farnesoid X receptor‐α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo
- BiologyFASEB journal : official publication of the Federation of American Societies for Experimental Biology
- 2019
The results suggest that the physiologic balance of FXR α expression and activation by bile acid is a key host metabolic pathway in the regulation of HBV infection and that FXRα can be envisioned as a target for HBV treatment.
Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress
- BiologyScientific Reports
- 2018
It is reported that peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 α) plays a central role in cisplatin-induced HBV transcription and replication and pharmacologic inhibition of ER stress impaired PGC-1α upregulation and HBV production induced by cisPlatin treatment.
Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes
- Biology, MedicineFASEB journal : official publication of the Federation of American Societies for Experimental Biology
- 2016
HBV replication and FXR regulation seem to be interdependent, and altered bile salt metabolism homeostasis might contribute to the persistence of HBV infection.
Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
- Biology, MedicineToxicology and applied pharmacology
- 2015
IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome
- BiologyPloS one
- 2015
It is shown that IL6 treatment leads to a reduction of cccDNA-bound histone acetylation paralleled by a rapid decrease in 3.5kb/pgRNA and subgenomic HBV RNAs transcription without affecting cCCDNA chromatinization or ccc DNA levels.
Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes
- BiologyClinical Epigenetics
- 2014
It is shown that the expression of several genes and the chromatin landscape become altered upon HBV infection, including global hypoacetylation of H2A.Z and H3K9, which could contribute to the HBV-induced pathomechanism in nontransformed hepatocytes.
Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target
- Biology, MedicineTumor Biology
- 2015
The focus of this review was to delineate the carcinogenesis effects of Sirt1 on HCC and present an overview of SIRT1 functions in normal liver followed by SIRT 1 roles in HCC, with focus on the underlying molecular mechanism to promote SIRT2 as a new therapeutic target for HCC.
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study
- Medicine, BiologyJournal of viral hepatitis
- 2021
Vonafexor was safe with a decline in HBV markers observed in CHB patients suggesting a potential anti‐viral effect the therapeutic potential of which has to be evaluated in larger trials.
References
SHOWING 1-10 OF 43 REFERENCES
PGC-1α controls hepatitis B virus through nutritional signals
- BiologyProceedings of the National Academy of Sciences
- 2006
It is concluded that HBV is tightly regulated by changes in the body's nutritional state through the metabolic regulator PGC-1α, a major metabolic regulator and a coactivator of key gluconeogenic genes, robustly coactivates HBV transcription.
Peroxisome Proliferator-Activated Receptor γ Coactivator 1α and Small Heterodimer Partner Differentially Regulate Nuclear Receptor-Dependent Hepatitis B Virus Biosynthesis
- BiologyJournal of Virology
- 2009
The effects of PGC1α and SHP on viral biosynthesis in the human hepatoma cell line Huh7 were similar to those observed in the nonhepatoma cells expressing ERRα and ERRγ, suggesting that these nuclear receptors may have a major role in governing HBV transcription and replication in this cell line.
Limited Effects of Fasting on Hepatitis B Virus (HBV) Biosynthesis in HBV Transgenic Mice
- BiologyJournal of Virology
- 2008
Fasting was shown to rather modestly increase the levels of viral proteins, transcripts, and replication intermediates in the HBV transgenic mouse model of chronic viral infection, suggesting that caloric restriction may modulate viremia to some extent during natural infection.
Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression
- Biology, MedicineLiver international : official journal of the International Association for the Study of the Liver
- 2011
The discovery of the mechanisms by which HBV is controlled by the hepatic metabolic milieu may broaden the understanding of the unique regulation of HBV expression and may also explain the mechanism by whichHBV induces liver pathologies.
Transactivation of the Hepatitis B Virus Core Promoter by the Nuclear Receptor FXRα
- BiologyJournal of Virology
- 2008
The data strongly suggest that FXRα is another member of the nuclear receptor superfamily implicated in the regulation ofHBV core promoter activity and that bile acids could play an important role in the natural history of HBV infection.
Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA‐1
- BiologyHepatology
- 2011
These findings provide a novel perspective on the role of miRNAs in host‐virus interactions in HBV infection and reverse cancer cell phenotype, which is apparently beneficial for HBV replication.
Hepatitis B virus X (HBX) protein upregulates β-catenin in a human hepatic cell line by sequestering SIRT1 deacetylase.
- Biology, ChemistryOncology reports
- 2012
It is proposed that HBX upregulates β-catenin by sequestering SIRT1, which leads to anticancer drug resistance and could be a therapeutic strategy for HBV-related hepatocellular carcinoma.
FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
- Biology, ChemistryCell metabolism
- 2009
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
- Biology, MedicineCell metabolism
- 2009
Peroxisome Proliferator-Activated Receptor-Coactivator 1 ( PGC-1 ) : Transcriptional Coactivator and Metabolic Regulator
- Biology
- 2003
PGC-1 constitutes one of the first and clearest examples in which biological programs are chiefly regulated by a transcriptional coactivator in response to environmental stimuli and its control of energy homeostasis suggests that it could be a target for antiobesity or diabetes drugs.